Access to Elsevier’s “Science Direct” On-Line Services
ID: HHS-NIH-OD-OLAO-SS-25-001Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH OLAOBETHESDA, MD, 20892, USA

NAICS

Periodical Publishers (513120)

PSC

NEWSPAPERS AND PERIODICALS (7630)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide continued access to Elsevier’s ScienceDirect, Embase, and Reaxys online services. The objective is to ensure NIH and HHS staff have uninterrupted access to a wide range of electronic journals and databases, which are critical for their research and administrative functions. This contract will support the NIH Library's mission by enhancing access to scientific literature, thereby improving productivity and efficiency among researchers and clinicians. Interested organizations must submit their capability statements by November 6, 2024, at 10 A.M. EST, and can direct inquiries to Oghogho Joy Ajao at ajaooj@mail.nih.gov.

    Point(s) of Contact
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Similar Opportunities
    DocuWare License and Annual Maintenance and Software Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm-fixed price contract for DocuWare License and Annual Maintenance and Software Support Services. This procurement aims to provide ongoing support for the DocuWare software system, which is critical for managing over 80,000 active medical and donor records within the Department of Transfusion Medicine, ensuring compliance with federal regulations. The NIH has determined that only DocuWare Corporation can fulfill this requirement without incurring significant costs associated with transitioning to a new vendor, including retraining and system redevelopment. Interested parties may express their interest and capabilities to Tasha Lowe at lowet2@mail.nih.gov by November 4, 2024, at 12 PM.
    Gibco EXPI293 Expression Media 6 x 1L, catalog # A1435102 and 2) EXPIFECTAMINE TRANSFXN KIT 10L 10L Kit Catalog# A14525
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of specific commercial items, namely the EXPI293 Expression Medium and the Expifectamine Transfection Kit, under solicitation number RFQ-NIAID-25-2244965. The procurement involves a total of 36 units of the expression medium to be delivered in six scheduled shipments from January to November 2025, along with one delivery of ten transfection kits, all adhering to strict quality and expiration date criteria. These products are critical for biological research and development, particularly in the fields of allergy and infectious diseases. Interested vendors must submit their proposals by October 30, 2023, via the NIH's electronic Simplified Acquisition Submission System (eSASS), and are required to be registered in the System for Award Management (SAM) prior to submission. For further inquiries, contact Calvin Robinson at calvin.robinson@nih.gov or by phone at 406-363-9214.
    Notice of Intent to Award Sole Source Non-Patent Literature (NPL): eJournals, eBooks, & Knovel Database RFI
    Active
    Commerce, Department Of
    The United States Patent and Trademark Office (USPTO) intends to award a sole source contract to Elsevier B.V. for a subscription to its collection of electronic journals, eBooks, and the Knovel database, aimed at enhancing patent quality and examiner efficiency. The procurement seeks a site license that will provide uninterrupted access to a wide range of peer-reviewed materials across various scientific disciplines, which are crucial for patent examination processes. This initiative underscores the importance of maintaining high-quality informational resources to support federal operations and decision-making, with the contract set to begin on January 1, 2025, and extend through December 31, 2025, with options for up to four additional years. Interested parties can direct inquiries to Michelle Ellis at Michelle.Ellis@USPTO.gov or Freddie Porter at Frederick.Porter@uspto.gov, with the notice emphasizing that responses must be submitted prior to the closure of this notice.
    R605--Various eJournals Subscription FY25 (VA-25-00010596)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from contractors for the procurement of various eJournal subscriptions for fiscal year 2025, as outlined in the Sources Sought Notice (36C776-24-AP-2240). The objective is to establish a Firm-Fixed-Price contract for a one-year period, providing access to a curated collection of key medical and health sciences journals that are essential for clinical decision-making across the VA healthcare system. This initiative is critical for enhancing the quality of care provided to veterans by ensuring that healthcare professionals have timely access to the latest research and clinical findings. Interested contractors must submit their capabilities, including business size and proof of publisher reseller status, by November 1, 2024, to Erich T. Hoffman at Erich.Hoffman@va.gov, with no obligation for the VA to provide feedback on submissions.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    NOTICE OF INTENT FOR ENTERPRISE TRUSTED SSL ANNUAL SERVICE SUBSCRIPTION
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with HID Global dba HydrantID for an annual renewal subscription of an Enterprise Trusted SSL license. This procurement is essential for maintaining secure communications and data integrity within the agency, reflecting the critical nature of SSL services in safeguarding sensitive information. The period of performance for this contract is set from December 15, 2024, to December 14, 2025, with interested vendors required to submit capability statements and letters of authorization to resell by 10:00 am on October 31, 2024, via the NIAID's electronic Simplified Acquisition Submission System (eSASS). For further inquiries, vendors may contact Leah Hinson at leah.hinson@nih.gov.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Notice of Intent to Sole Source; 3M Health Information Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to 3M Health Information Systems for the acquisition of the 360 Encompass application. This procurement aims to replace the existing 3M Clinical Abstracting (ClinTrac) system, which is being phased out by the vendor, ensuring continuity in health information management services. The 360 Encompass application is critical for clinical documentation improvement, coding excellence, and computer-assisted coding, and it integrates seamlessly with the NIH's existing infrastructure, minimizing additional costs and implementation time associated with switching vendors. Interested parties may submit their capabilities and interest to Kristin Nagashima at kristin.nagashima@nih.gov by November 6, 2024, at 3 PM EST.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, manufacture, and distribute a variety of drug compounds, including controlled substances, to support drug abuse and addiction research. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement, is expected to span five years and will allow for both cost reimbursement and fixed-price task orders based on NIDA's needs. Interested offerors must submit their proposals electronically by November 15, 2024, and ensure compliance with federal acquisition regulations, including maintaining active registration in the System for Award Management (SAM). For further inquiries, potential bidders can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov.